Increasing Osteoarthritis Cases Boost Demand Of Plasma Therapy Market Is Supporting Development Across The Plasma Therapy Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Are The Forecasted Market Size Figures For The Plasma Therapy Market In 2026 And 2030?

The plasma therapy market has experienced substantial expansion recently. Projections indicate it will expand from $0.61 billion in 2025 to $0.69 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 12.6%. The historical growth was influenced by factors such as limited public understanding of plasma therapy benefits, a prevailing dependence on conventional treatments, the rise in orthopedic and sports medicine procedures, expanding hospital and clinic infrastructure, and the initial integration of PRP in cosmetic applications.

The plasma therapy market is anticipated to experience significant expansion in the coming years, with its size projected to reach $1.13 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.0%. This growth during the forecast period is attributed to several factors, including the development of advanced PRP and PRF formulations, an increase in regenerative medicine research, the broadening of plasma therapy applications in chronic and cardiac injuries, rising adoption in dermatology and dental care, and the expansion of clinical trials and research institutes. Key trends anticipated in the forecast period involve the growing acceptance of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) therapies, the expansion of regenerative medicine and orthopedic applications, increased utilization in dermatology, hair restoration, and plastic surgery, a rising demand for injectable and membrane-based fibrin products, and the integration of research with clinical trials to achieve enhanced therapeutic outcomes.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3278&type=smp

Which Significant Factors Are Encouraging Growth In The Plasma Therapy Market?

An anticipated increase in osteoarthritis incidents is projected to propel the plasma therapy market throughout the forecast period. Platelet-rich plasma (PRP), a form of plasma therapy, is recognized as a secure and effective therapeutic option for osteoarthritis. PRP, an autologous blood growth factor in concentrated form, is administered via joint injection to alleviate symptoms by reducing inflammation and impeding the advancement of osteoarthritis. Illustratively, a report from September 2023 by the Journal of Elsevier, a Netherlands-based publishing firm, indicates that by 2050, the global increase in osteoarthritis cases is anticipated to reach 74.9% (ranging from 59.4% to 89.9%) for the knee, 48.6% (ranging from 35.9% to 67.1%) for the hand, 78.6% (ranging from 57.7% to 105.3%) for the hip, and 95.1% (ranging from 68.1% to 135.0%) for other categories of osteoarthritis. Among the widely utilized treatments for osteoarthritis are autologous chondrocyte implantation and scaffold implants. Consequently, an escalating incidence of osteoarthritis is foreseen to stimulate growth in the plasma therapy market.

Which Segment-Based Categories Are Covered In The Plasma Therapy Market?

The plasma therapy market covered in this report is segmented –

1) By Type: Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)

2) By Application: Orthopedics, Arthritis, Chronic Tendinitis, Bone Repair & Regeneration, Dermatology, Androgenic Alopecia, Plastic Surgery, Dental, Cardiac Muscle Injury, Other Applications

3) By End-Users: Hospitals & Clinics, Laboratories: Research Institutes

Subsegments:

1) By Pure PRP: High Concentration PRP, Low Concentration PRP

2) By Leukocyte-Rich PRP: PRP With White Blood Cells, PRP With Growth Factors

3) By Pure Platelet-rich Fibrin (PRF): Injectable PRF, Membrane PRF

4) By Leukocyte-rich Fibrin (L-PRF): L-PRF Clots, L-PRF Membranes

Which Trends Are Supporting The Evolution Of The Plasma Therapy Market?

Leading companies operating in the plasma therapy market are introducing innovative products such as the ESG-410 to address evolving needs and enhance treatment possibilities. The ESG-410 is an Electrosurgical Generator designed to provide versatile options and efficiencies in managing NMIBC (non-muscle-invasive bladder cancer) and benign prostatic hyperplasia. For instance, in June 2023, Olympus Corporation, a Japan-based medical technology company, launched this next-generation electrosurgical generator, the ESG-410. It is utilized for treating bladder cancer and enlarged prostate. The ESG-410 incorporates advanced design components, such as enhanced capacitors, which ensure superior plasma stability during ignition. It boasts rapid ignition and optimized plasma stability, delivering improvements over the ESG-400, especially when deployed with various loop sizes and oval buttons. The ESG-410 Electrosurgical Generator provides advanced treatment alternatives for NMIBC and BPH by offering a comprehensive range of resection loops, electrodes, and vaporization tools.

Who Are The Key Market Participants In The Plasma Therapy Market?

Major companies operating in the plasma therapy market are Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., Arthrex Inc., Biotest AG, China Biologic Products Holdings Inc., DePuy Synthes Companies, CSL Limited, Grifols S.A., Octapharma AG, Terumo BCT Inc., Pfizer Inc., Kedrion Biopharma, ADMA Biologics Inc., SK Plasma Co. Ltd., Kamada Ltd., Fusion HealthCare, LFB Plasma, Baxter International Inc., Bayer AG, GC Biopharma Corp, Hualan Biological Engineering Inc., Japan Blood Products Organization, PlasmaCare Inc., ProMetic Life Sciences Inc., Sanquin, Shanghai RAAS Blood Products Co. Ltd., Canadian Plasma Resources, B Positive Plasma, Proesis Biologics Inc.

Access The Complete Plasma Therapy Market Report:

https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report

Which Region Holds The Largest Share In The Plasma Therapy Market?

North America was the largest region in the plasma therapy market in 2025. The Middle East is expected to be the fastest-growing region in the global plasma therapy market share during the forecast period. The regions covered in the plasma therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Plasma Therapy Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=3278&type=smp

Browse Through More Reports Similar to the Global Plasma Therapy Market 2026, By The Business Research Company

Apheresis Consumables And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/apheresis-consumables-and-equipment-global-market-report

Blood Transfusion Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Hematology Analyzers And Reagents Market Report 2026

https://www.thebusinessresearchcompany.com/report/hematology-analyzers-and-reagents-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795